https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/accounts-payable https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/additional-paid-in-capital https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/capital-units-authorized https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/cash https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/cash-flow-breakdown https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/commitments-and-contingencies https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/common-stock-value https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/contract-liability https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/current-assets https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/current-liabilities https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/due-from-related-parties-current https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/effective-tax-rate https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/general-and-administrative-expense https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/income-tax https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/income-taxes-paid https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/increase-decrease-in-accounts-receivable-related-parties https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/interest-expense https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/interest-paid-net https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/interest-payable-current https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/net-change-in-cash https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/net-income https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/operating-cash-flow https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/operating-expenses https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/operating-income https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/preferred-shares-facts https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/preferred-stock-value https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/prepaid-expense-current https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/pretax-income https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/proceeds-from-contributions-from-parent https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/profit-loss https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/public-float https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/related-party-costs https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/research-and-development https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/retained-earnings https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/revenue https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/shareholders-equity https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/shares-authorized https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/shares-issued https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/total-assets https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/nugenerex-immuno-oncology-inc/weighted-average-number-of-share-outstanding-basic-and-diluted